Waegener signs clinical software agreement with SDS-Medical; Beijing Union buys Instem's Provantis preclinical software;

> Devices company Waegener has signed a clinical trial software agreement with SDS-Medical Software Solutions. Press release

> At the annual UCSF School of Medicine leadership retreat, the discussions focused on the deluge of data and the bioinformatics capabilities needed to cope with it. Article

> Chinese company Beijing Union has purchased Instem's Provantis preclinical software solution. Press release

> Almac has launched a next-generation sequencing (NGS) data analysis service. Press release

> Researchers from Hong Kong have used computer simulation to propose a strategy for complete prokaryotic genomic sequencing. Abstract

> A new computational approach from the U.S. and Italy has found Duchenne muscular dystrophy biomarkers. Article

> In silico tumor dynamics could lead to new routes for anti-tumor treatment. Abstract

> BioStat International has received trademark status for its proprietary, web-based clinical trial data management software, rED Cap. Article

> TranscriptomeBrowser 3.0 could help researchers access known and predicted molecular interactions. Abstract

> Gene/protein networks are increasingly important in drug development, and a new software package--graphite--may help reduce pathway complexity. Abstract

> BMC Bioinformatics has published a special issue on "Semantic Web Applications and Tools for Life Sciences (SWAT4LS) 2010." Table of contents

And Finally... An Indiana University Ph.D. student has received $50K from Persistent Systems to develop software to identify and quantify glycopeptides from mass spectrometry data. Press release

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.